LVA surgery for Alzheimer's disease
Part of Brain & nervous system clinical trials.
This study tests a surgery called lymphaticovenous anastomosis (LVA) as a possible treatment for Alzheimer's disease. The surgery connects tiny lymph vessels to veins to help clear waste from the brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 85 years old.
- You have been diagnosed with Alzheimer's disease using brain scans, spinal fluid tests, or other medical evidence.
- You have a caregiver (like a family member) who can live with you and help.
- You are healthy enough to handle surgery and general anesthesia.
- You do not have serious heart, liver, or kidney problems, or a bleeding disorder.
- You agree to the surgery and are willing to follow up with the study team.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a surgery that connects tiny lymph vessels to veins in the neck area to help drain waste from the brain. It aims to see if this surgery can improve symptoms of Alzheimer's disease and understand how it works.
This trial tests a surgery that targets the lymphatic system in the neck to help people with moderate-to-severe Alzheimer's disease. The goal is to see if it can improve cognitive function.
This study is for people with Alzheimer's disease who have already had a neck surgery to improve fluid drainage (called DC-LVA). Researchers want to see how this surgery affects thinking and memory over time, and they will follow participants to learn more.
This trial tests a surgery called lymphaticovenular anastomosis (LVA) that aims to improve brain drainage in people with Alzheimer's disease. It may help by clearing waste proteins from the brain, potentially slowing the disease.
This trial tests a surgery that connects lymph vessels in the neck to help clear waste from the brain, which may slow down memory loss in people with moderate Alzheimer's disease. It is for patients who have not improved with standard medications.
This study tests a surgical procedure to connect lymph vessels in the neck to veins, which may help clear waste from the brain in people with mild cognitive impairment or mild to moderate Alzheimer's disease. It is for patients who have not improved after at least 3 months of standard care.
Hear when a new Alzheimer's Disease (AD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.